These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3954815)

  • 1. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
    Dorow P; Weiss T; Felix R; Köhler M
    Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-acetylcysteine in subjects with slow pulmonary mucociliary clearance.
    Todisco T; Polidori R; Rossi F; Iannacci L; Bruni B; Fedeli L; Palumbo R
    Eur J Respir Dis Suppl; 1985; 139():136-41. PubMed ID: 3862607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral N-acetylcysteine on mucus clearance.
    Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
    Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lysine stepronin salts on mucociliary clearance].
    Olivieri D; Bernareggi V; Quitadamo M
    Arch Monaldi; 1985; 40(5-6):211-7. PubMed ID: 3843171
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of tasuldine, a bronchosecretolytic agent, on mucus rheology and clearability and the interaction with acetylcholine in ferrets.
    App EM; Tomkiewicz RP; Hahn HL; Engler H; Vergin H; King M
    Pulm Pharmacol Ther; 1997; 10(5-6):271-6. PubMed ID: 9778490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetylcysteine and mucociliary activity in mammalian airways.
    Iravani J; Melville GN; Horstmann G
    Arzneimittelforschung; 1978; 28(2):250-4. PubMed ID: 580387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
    Dorow P; Weiss T
    Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of myrtol standardized and other substances on the respiratory tract: ciliary beat frequency and mucociliary clearance as parameters.
    Begrow F; Böckenholt C; Ehmen M; Wittig T; Verspohl EJ
    Adv Ther; 2012 Apr; 29(4):350-8. PubMed ID: 22477544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucociliary clearance in patients with chronic obstructive bronchopneumopathy: study made with millimicrospheres of albumin labeled with 99mTc].
    Banfi F; Camisasca E; Salvotelli V; Borasi G; Bertoli L
    Arch Monaldi; 1982; 37(1-2):71-80. PubMed ID: 7187728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional mucociliary clearance in patients with small-airways disease (author's transl)].
    Weiss T; Dorow P; Felix R
    Prax Klin Pneumol; 1981 Jul; 35(7):327-30. PubMed ID: 7345429
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug effects on mucociliary function.
    Pavia D; Sutton PP; Lopez-Vidriero MT; Agnew JE; Clarke SW
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():304-17. PubMed ID: 6137400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimizing of therapy with theophylline preparations in obstructive respiratory diseases. 4. Effect of theophylline on mucociliary clearance and maximal inspiratory mouth occlusion pressure].
    Schmidt G; Ranke C; Creutzig H; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Apr; 37(4):154-60. PubMed ID: 6866926
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.
    Rochat T; Lacroix JS; Jornot L
    J Cell Physiol; 2004 Oct; 201(1):106-16. PubMed ID: 15281093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucolytic agents and mucociliary activity.
    Gunnarsson M; Hybbinette JC; Mercke U
    Rhinology; 1984 Dec; 22(4):223-31. PubMed ID: 6151739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ambroxol on tracheobronchial clearance in simple chronic bronchitis.
    Ericsson CH; Juhász J; Mossberg B; Philipson K; Svartengren M; Camner P
    Eur J Respir Dis; 1987 Mar; 70(3):163-70. PubMed ID: 3569448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.